

The Commercial Space Company![]()
....
Astronaut Story Musgrave operating the Optical DMDA on board Shuttle flight STS-80.
Space Shuttle Columbia carrying ITAs CMIX-5 payload, climbs skyward on the STS-80 mission.
ITA:
ITA protects your proprietary rights:
STS067 Astronaut William G.
Gregory, pilot, works with a pharmaceutical experiment on the
middeck of the Earth-orbiting Space Shuttle Endeavour during the
STS-67 mission. Commercial Materials Dispersion Apparatus
Instrumentation Technology Associates Experiments (CMIX-03)
includes not only pharmaceutical, but also biotechnology, cell
biology, fluids, and crystal growth investigations.
STS-37 Commander Steven R. Nagel
(left) and Mission Specialist (MS) Jerome Apt shake a cell
syringe during a test with the Bioserve Instrumentation
Technology Associates Materials Dispersion Apparatus (BIMDA)
bioprocessing test bed. The crewmembers are on the middeck of
Atlantis, Orbiter Vehicle (OV) 104. The BIMDA payload was
developed and built by ITA, and flown jointly under the auspices
of BioServe Space Technologies, a NASA Center for Commercial
Development of Space (CCDS) located at the University of
Colorado. Also collaborating on the BIMDA activity are
researchers from NASA Johnson Space Center (JSC) in Texas and
Ames Research Center (ARC) in California. Apt stands near the
sleep restraints attached to the starboard wall.
For
further information about ITA or to receive a brochure, please
send us EMAIL 